Amarin Corp Plc (AMRN)

[BioChica]

If it reduces CV Risk, that's a good thing it validates EPA treatment for CVD, even if it accomplishes 15% Reduction. The placebo is another matter.

P.S. They will not be sell this drug in the U.S., patent protection stopped EPANOVA drug sales in the U.S.